Related Experiment Video
Updated: Aug 10, 2026
The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
[Evaluation of BRM in skin cancer]
1Dept. of Dermalobogy, National Cancer Center Hospital.
Abstract:
Biological response modifiers (BRMs) strengthen the host defense mechanism/subsequently producing therapeutic effects against neoplastic and other diseases. Many kinds of BRM are applied for malignant skin tumors. Administration is both systemic and intratumoral, evaluable lesions can be measured in one, two and three directions. Furthermore there are also methods for judging the effects by clinical symptoms. These involve evaluation of macroscopic effect, from which it is possible histopathological judgement. Therefore, the evaluation of effects on skin cancer is very complex, and a new method is necessary. Accordingly we devised a method of judgement summarizing these evaluation procedures.
Insights
Biological response modifiers (BRMs) enhance host defenses for treating diseases. A new, comprehensive evaluation method is needed for complex skin cancer treatment assessments.
Area of Science:
- Immunology
- Oncology
- Dermatology
Context:
- Biological response modifiers (BRMs) are utilized in treating various diseases, including malignant skin tumors.
- Current treatment evaluation involves systemic or intratumoral administration with complex measurement and clinical symptom assessments.
- Existing methods for judging BRM efficacy in skin cancer are multifaceted and require simplification.
Purpose:
- To address the complexity of evaluating treatment effects for malignant skin tumors using biological response modifiers.
- To develop a novel, integrated method for assessing therapeutic outcomes in skin cancer.
- To streamline the complex evaluation procedures currently employed for skin cancer treatment.
Summary:
- Biological response modifiers (BRMs) bolster the immune system to combat neoplastic diseases.
- Evaluating BRM efficacy in malignant skin tumors is complex, involving multiple measurement directions and clinical/histopathological assessments.
- A new, consolidated judgment method has been devised to simplify and improve the evaluation of BRM effects on skin cancer.
Impact:
- This new method aims to simplify the complex evaluation of biological response modifiers in skin cancer treatment.
- It provides a more streamlined approach to assessing therapeutic efficacy.
- Facilitates better understanding and application of BRMs in dermatological oncology.
